Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report)’s stock price was down 5.2% during trading on Friday . The stock traded as low as $10.10 and last traded at $10.10. Approximately 5,242 shares traded hands during trading, an increase of 948% from the average daily volume of 500 shares. The stock had previously closed at $10.65.
Ascentage Pharma Group International Trading Down 5.2%
The firm has a fifty day moving average of $7.26 and a 200 day moving average of $6.32.
About Ascentage Pharma Group International
Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- What is Put Option Volume?
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- How to Calculate Return on Investment (ROI)
- Lululemon Share Price Has Plenty of Room Left to Fall
- What Do S&P 500 Stocks Tell Investors About the Market?
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
